Send us a text

Jonah Lupton is a prolific entrepreneur who is known for his various start-up companies, including Lupton Capital. He has gained particular renown for beginning Lupton Media, SoundGuard, and Nutraspire. Born and raised in Boston, Massachusetts, Jonah earned his Bachelor's of Science degree in business Management from Salve Regina University in 2002. He began his professional career working in finance, before resigning to pursue entrepreneurship in 2011. In 2012, he became an early investor in Cauzly.com. Following the website's relaunch in 2015, he became the CEO. In this episode of How To Trade It, Jonah and Casey talk about how to find stocks that will perform well in terrible market conditions. You don’t want to miss it!

Subscribe to How To Trade It

You’ll want to listen to this episode, if you are interested in hearing Jonah discuss…

• [01:33] His daily routine
• [03:47] Biggest position right now
• [13:59] Trimming positions
• [21:31] His focus for 2023
• [35:29] Getting connected

CELSIUS 
Jonah is adamant about researching the companies of the stocks he invests in.  Since his biggest position right now is Celsius Holdings, Inc. (CELH on Nasdaq), Jonah knows a thing or two about their proprietary, flagship brand CELSIUS.  He’s a big fan actually.  This revolutionary fitness drink comes in several delicious sparkling and non-carbonated flavors, and in powder stick packets that you can add to water.  Unlike many of its primary, energy drink competitors, CELSIUS has no preservatives, no aspartame, no high fructose corn syrup, is non-GMO, with no artificial flavors or colors, and no added sodium.  It’s kosher and vegan certified, soy, gluten, and sugar free too.   If you haven’t tried them yet, grab yourself some CELSIUS today!  

The two biggest sectors
Medical Technology and Energy have been the two biggest sectors that I’ve been trading in recent years. I’ve reduced my energy involvement in the last four or five months because I think it has topped out for now.  However, my portfolio is about 25% Med Tech at this point.  It’s very heavy because I think Healthcare and Med Tech are both good, at least through the end of this year and early into the next.  They give you an offense and a defense. Medical devices, procedures, and surgeries are going to continue to happen, regardless of what the FED is doing, where inflation is, or what the economy as a whole looks like. These companies should typically perform well in any economic cycle.      

Resources & People Mentioned

• Substack
• Stocktwits
• Seeking Alpha
• CELSIUS fitness drinks

Grab your copy of the Complete Trading System This book teaches you how to build a trading system from the ground up and how to become profitable in the markets.

Support the show

📈Replace Your Income Transform your life:

Join Now:
Replace Your Income With Freedom Income Options

🔗 Explore all my tools, trade alerts, and social links:
👉 https://linktr.ee/caseystubbs

Casey Stubbs
Freedom Income Options
Replace Your Paycheck, Reclaim Your Freedom.